ICSH guidance for INR and D-dimer testing using point of care testing in primary care

David A Fitzmaurice; Geert-Jan Geersing; Xavier Armoiry; Sam Machin; Steve Kitchen; Ian Mackie

doi:10.1111/ijlh.14051

ICSH guidance for INR and D-dimer testing using point of care testing in primary care

Int J Lab Hematol. 2023 Jun;45(3):276-281. doi: 10.1111/ijlh.14051. Epub 2023 Mar 7.

Authors

David A Fitzmaurice¹, Geert-Jan Geersing², Xavier Armoiry³, Sam Machin⁴, Steve Kitchen⁵, Ian Mackie⁴

Affiliations

¹ Warwick Medical School, University of Warwick, Coventry, UK.
² Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
³ Claude Bernard University Lyon 1, Lyon School of Pharmacy (ISPB), Lyon, France.
⁴ Research Haematology Department, University College London, London, UK.
⁵ Sheffield Haemophilia and Thrombosis Centre, Sheffield, UK.

PMID: 36882063
DOI: 10.1111/ijlh.14051

Abstract

This guideline has been written on behalf of the International Council for Standardisation in Haematology (ICSH) and focuses on two point of care haematology tests used within primary care, namely International Normalised Ratio (INR) and D-dimer. Primary care covers out of hospital settings and can include General Practice (GP), Pharmacy and other non-hospital settings (although these guidelines would also be applicable to hospital out-patient settings). The recommendations are based on published data in peer reviewed literature and expert opinion; they should supplement regional requirements, regulations or standards.

Keywords: D-dimer; INR; point of care testing; primary care.

Publication types

Review

MeSH terms

Hematologic Tests*
Humans
International Normalized Ratio
Point-of-Care Testing*
Primary Health Care

Substances

fibrin fragment D